Oncology What will ASCO 2026 reveal about oncology innovation’s new g... The next leaders in oncology will be the ones built to adapt in real time.
Digital From data to deployment: Navigating AI adoption in pharma wi... Explore our video interview for expert tips on AI adoption in pharma, featuring Veeva.
Sales & Marketing Sponsored Solution Spotlight: Medscape One Medscape One (M1) is a sophisticated, AI-powered decision engine designed to redefine HCP engagement.
Digital The real test for healthtech companies isn’t innovation – it... The Basel Area is increasingly becoming a convergence point where life sciences, advanced computing, and health technology intersect.
Market Access Views from Asembia: EVERSANA's take on outsourcing, AI, and ... Following Asembia 2026, pharmaphorum spoke with Krista Pinto, a leading commercialisation expert at EVERSANA.
Patients More than a discount: How intelligent copay programmes are r... Brian Laird explains a more dynamic, data-driven approach to copay is redefining affordability, creating a new standard for balancing patient support.
Oncology ASCO 2026: Chinese firms take a front seat in oncology, with... Dr Li Mao and Dr Giovanni Selvaggi of Betta Pharmaceuticals and Xcovery Holdings discuss their novel ALK inhibitor and the Chinese biotech landscape.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
